Treatment of Lymphoma, Chronic Lymphocytic Leukemia and Plasma Cell Disorders Including Myeloma as recommended by BC Cancer.

In recent years the treatment of the lymphomas, leukemias and related conditions has grown steadily more complex.

The policies described in this section of BC Cancer's Cancer Management Manual have been kept as up-to-date as possible; however, active consultation with the staff of BC Cancer and regional consultants in medical oncology and hematology should be sought, especially in unusual or rare conditions. In addition, most of the conditions described here still require improved treatment which will only come about through continued careful clinical investigation and research. Active consultation will allow you to be aware of these investigative efforts so that you may hear of the most current results and participate in the actual research efforts. Your past support of such investigations has kept British Columbia at the forefront of lymphoma treatment and further improvements can only be made if that support continues.

The members of the Lymphoma Tumour Group would appreciate your feedback concerning any of these policies. Contact any member or the chair with your questions or suggestions.

Updated 28 July 2008

Other plasma cell disorders (for example, heavy chain disease) are quite rare in British Columbia and their optimal management must be individualized. Please consult one of the medical oncology members of the Lymphoma Tumour Group at one of the BC Cancer Centers for recommendations concerning evaluation and management of these patients.

Revised Dec 2014

Patient and Family Counselling Services offers a number of support programs and services to patients and their families. For more information please contact 604.877.6000, local 2194 or toll free at 1.800.663.3333 local 2194.

The Library at 604.675.8001 or toll free: 1.888.675.8001 ext. 8001 is a valuable resource.

Patient information regarding osteonecrosis of the jaw

Patient information for the use of topical nitrogen mustard: Ointment (PDF)

The Lymphoma, Chronic Leukemia, Myeloma Tumour Groups are multidisciplinary teams that include medical oncologists, radiation oncologists, surgical oncologists, hematologists, neuro-oncologists, pathologists, radiologists, pharmacists, nurses and many others from cancer centres and health authorities within British Columbia.

Lymphoma Chair

Dr. L. Sehn, Medical Oncology, VC

Myeloma Chair

Dr. L. Foltz, Hematologist, St Paul's Hospital

Updated: March 8, 2023